These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 12206636)

  • 21. IMRiS phase II study of IMRT in limb sarcomas: Results of the pre-trial QA facility questionnaire and workshop.
    Simões R; Miles E; Yang H; Le Grange F; Bhat R; Forsyth S; Seddon B
    Radiography (Lond); 2020 Feb; 26(1):71-75. PubMed ID: 31902458
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Questionnaire based quality assurance for the RT01 trial of dose escalation in conformal radiotherapy for prostate cancer (ISRCTN 47772397).
    Mayles WP; Moore AR; Aird EG; Bidmead AM; Dearnaley DP; Griffiths SE; Warrington AP;
    Radiother Oncol; 2004 Nov; 73(2):199-207. PubMed ID: 15622611
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Three-dimensional distribution of radiation within the breast: an intercomparison of departments participating in the START trial of breast radiotherapy fractionation.
    Venables K; Winfield EA; Aird EG; Hoskin PJ
    Int J Radiat Oncol Biol Phys; 2003 Jan; 55(1):271-9. PubMed ID: 12504061
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quality assurance of axillary radiotherapy in the EORTC AMAROS trial 10981/22023: the dummy run.
    Hurkmans CW; Borger JH; Rutgers EJ; van Tienhoven G; ;
    Radiother Oncol; 2003 Sep; 68(3):233-40. PubMed ID: 13129630
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The potential impact of treatment variations on the results of radiotherapy of the internal mammary lymph node chain: a quality-assurance report on the dummy run of EORTC Phase III randomized trial 22922/10925 in Stage I--III breast cancer(1).
    Poortmans PM; Venselaar JL; Struikmans H; Hurkmans CW; Davis JB; Huyskens D; van Tienhoven G; Vlaun V; Lagendijk JJ; Mijnheer BJ; De Winter KA; Van der Hulst MH; Van den Bogaert WF
    Int J Radiat Oncol Biol Phys; 2001 Apr; 49(5):1399-408. PubMed ID: 11286848
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Implementing the UK Medical Research Council (MRC) RT01 trial (ISRCTN 47772397): methods and practicalities of a randomised controlled trial of conformal radiotherapy in men with localised prostate cancer.
    Sydes MR; Stephens RJ; Moore AR; Aird EG; Bidmead AM; Fallowfield LJ; Graham J; Griffiths S; Mayles WP; McGuire A; Stanley S; Warrington AP; Dearnaley DP;
    Radiother Oncol; 2004 Aug; 72(2):199-211. PubMed ID: 15297138
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regional radiotherapy to axilla and supraclavicular fossa for adjuvant breast treatment: a comparison of four techniques.
    Jephcott CR; Tyldesley S; Swift CL
    Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):103-10. PubMed ID: 15337545
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quality assurance of EORTC trial 22922/10925 investigating the role of internal mammary--medial supraclavicular irradiation in stage I-III breast cancer: the individual case review.
    Poortmans P; Kouloulias VE; Venselaar JL; Struikmans H; Davis JB; Huyskens D; van Tienhoven G; Hurkmans C; Mijnheer B; Van den Bogaert W
    Eur J Cancer; 2003 Sep; 39(14):2035-42. PubMed ID: 12957458
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Morbidity related to axillary irradiation in the treatment of breast cancer.
    Bentzen SM; Dische S
    Acta Oncol; 2000; 39(3):337-47. PubMed ID: 10987231
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analysis of a large number of clinical studies for breast cancer radiotherapy: estimation of radiobiological parameters for treatment planning.
    Guerrero M; Li XA
    Phys Med Biol; 2003 Oct; 48(20):3307-26. PubMed ID: 14620060
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of positioning uncertainty and breathing on dose delivery and radiation pneumonitis prediction in breast cancer.
    Mavroidis P; Axelsson S; Hyödynmaa S; Rajala J; Pitkänen MA; Lind BK; Brahme A
    Acta Oncol; 2002; 41(5):471-85. PubMed ID: 12442924
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Breast radiotherapy: an Australasian survey of current treatment techniques.
    Delaney G; Blakey D; Drummond R; Kenny L; Centre RO
    Australas Radiol; 2001 May; 45(2):170-8. PubMed ID: 11380359
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Target volume definition and target conformal irradiation technique for breast cancer patients.
    Kiricuta IC; Götz U; Schwab F; Fehn M; Neumann HH
    Acta Oncol; 2000; 39(3):429-36. PubMed ID: 10987242
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Implementation of Royal College of Radiologists Consensus Statements and National Institute for Health and Care Excellence Guidance: Breast Radiotherapy Practice in the UK.
    Locke I; Drinkwater K
    Clin Oncol (R Coll Radiol); 2021 Jul; 33(7):419-426. PubMed ID: 33597107
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Axillary lymph node dose with tangential breast irradiation.
    Reed DR; Lindsley SK; Mann GN; Austin-Seymour M; Korssjoen T; Anderson BO; Moe R
    Int J Radiat Oncol Biol Phys; 2005 Feb; 61(2):358-64. PubMed ID: 15667953
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quality assurance of the EORTC trial 22881/10882: "assessment of the role of the booster dose in breast conserving therapy": the Dummy Run. EORTC Radiotherapy Cooperative Group.
    van Tienhoven G; van Bree NA; Mijnheer BJ; Bartelink H
    Radiother Oncol; 1991 Dec; 22(4):290-8. PubMed ID: 1792323
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment planning and delivery of involved field radiotherapy in advanced Hodgkin's disease: results from a questionnaire-based audit for the UK Stanford V regimen vs ABVD clinical trial quality assurance programme (ISRCTN 64141244).
    Diez P; Hoskin PJ; Aird EG
    Br J Radiol; 2007 Oct; 80(958):816-21. PubMed ID: 17959922
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Breast cancer regional radiation fields for supraclavicular and axillary lymph node treatment: is a posterior axillary boost field technique optimal?
    Wang X; Yu TK; Salehpour M; Zhang SX; Sun TL; Buchholz TA
    Int J Radiat Oncol Biol Phys; 2009 May; 74(1):86-91. PubMed ID: 18805650
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of three-dimensional versus intensity-modulated radiotherapy techniques to treat breast and axillary level III and supraclavicular nodes in a prone versus supine position.
    Sethi RA; No HS; Jozsef G; Ko JP; Formenti SC
    Radiother Oncol; 2012 Jan; 102(1):74-81. PubMed ID: 21993404
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dummy run of quality assurance program in a phase 3 randomized trial investigating the role of internal mammary lymph node irradiation in breast cancer patients: Korean Radiation Oncology Group 08-06 study.
    Chung Y; Kim JW; Shin KH; Kim SS; Ahn SJ; Park W; Lee HS; Kim DW; Lee KC; Suh HS; Kim JH; Shin HS; Kim YB; Suh CO
    Int J Radiat Oncol Biol Phys; 2015 Feb; 91(2):419-26. PubMed ID: 25636764
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.